Introduction:Basic information about CAS 85466-18-8|Thymopoietin II: 32-35, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Thymopoietin II: 32-35 |
|---|
| CAS Number | 85466-18-8 | Molecular Weight | 516.59200 |
|---|
| Density | 1.45g/cm3 | Boiling Point | / |
|---|
| Molecular Formula | C21H40N8O7 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | (2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoic acid |
|---|
| Synonym | More Synonyms |
|---|
Thymopoietin II: 32-35 BiologicalActivity
| Description | Thymocartin (Thymopoietin II (32-35)) is the 32-35 fragment of the thymic factor (thymopoietin). Thymocartin has shown potential for immunodeficiency diseases research[1][2]. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Inflammation/Immunology |
|---|
| References | [1]. S Lang, et al. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol. 1996 Nov;48(11):1190-6. [2]. Ch B Felder, et al. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters. J Microencapsul. 2003 Sep-Oct;20(5):553-67. |
|---|
Chemical & Physical Properties
| Density | 1.45g/cm3 |
|---|
| Molecular Formula | C21H40N8O7 |
|---|
| Molecular Weight | 516.59200 |
|---|
| Exact Mass | 516.30200 |
|---|
| PSA | 275.84000 |
|---|
| LogP | 1.13990 |
|---|
| Index of Refraction | 1.619 |
|---|
| InChIKey | COIXXKVZEXZCLU-YXWQFLTLSA-N |
|---|
| SMILES | CC(C)C(NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(N)CCCN=C(N)N)C(=O)O |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- YV9384000
- CHEMICAL NAME :
- L-Valine, N-(N-(N(sup 2)-L-arginyl-L-lysyl)-L-alpha-aspartyl)-
- CAS REGISTRY NUMBER :
- 85466-18-8
- LAST UPDATED :
- 199410
- DATA ITEMS CITED :
- 3
- MOLECULAR FORMULA :
- C21-H40-N8-O7
- MOLECULAR WEIGHT :
- 516.69
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD - Lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >1 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
- TYPE OF TEST :
- LD - Lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >1 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
- TYPE OF TEST :
- LD - Lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- >1 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
|
Synonyms
| Rgh 0206 |
| Thymocartina [INN-Spanish] |
| Thymocartine [INN-French] |
| Thymocartinum [INN-Latin] |
| Thymocartina |
| Thymocartin |
| Thymopoietin II: 32-35 |